Observational studyThe Pan African medical journal2026

Clinical outcomes and toxicity in metastatic breast cancer patients treated with first or second-line cyclin-dependent kinase (CDK) 4/6 inhibitors and endocrine therapy in Egypt.

Hesham Mahmoud ElWakeel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.